Disruption of mitochondrial complex I induces progressive parkinsonism

Nature. 2021 Nov;599(7886):650-656. doi: 10.1038/s41586-021-04059-0. Epub 2021 Nov 3.

Abstract

Loss of functional mitochondrial complex I (MCI) in the dopaminergic neurons of the substantia nigra is a hallmark of Parkinson's disease1. Yet, whether this change contributes to Parkinson's disease pathogenesis is unclear2. Here we used intersectional genetics to disrupt the function of MCI in mouse dopaminergic neurons. Disruption of MCI induced a Warburg-like shift in metabolism that enabled neuronal survival, but triggered a progressive loss of the dopaminergic phenotype that was first evident in nigrostriatal axons. This axonal deficit was accompanied by motor learning and fine motor deficits, but not by clear levodopa-responsive parkinsonism-which emerged only after the later loss of dopamine release in the substantia nigra. Thus, MCI dysfunction alone is sufficient to cause progressive, human-like parkinsonism in which the loss of nigral dopamine release makes a critical contribution to motor dysfunction, contrary to the current Parkinson's disease paradigm3,4.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axons / drug effects
  • Axons / metabolism
  • Axons / pathology
  • Cell Death
  • Dendrites / metabolism
  • Dendrites / pathology
  • Disease Models, Animal
  • Disease Progression
  • Dopamine / metabolism
  • Dopaminergic Neurons / drug effects
  • Dopaminergic Neurons / metabolism
  • Dopaminergic Neurons / pathology
  • Electron Transport Complex I / genetics*
  • Electron Transport Complex I / metabolism*
  • Female
  • Levodopa / pharmacology
  • Levodopa / therapeutic use
  • Male
  • Mice
  • Motor Skills / drug effects
  • NADH Dehydrogenase / deficiency
  • NADH Dehydrogenase / genetics
  • Parkinsonian Disorders / drug therapy
  • Parkinsonian Disorders / metabolism*
  • Parkinsonian Disorders / pathology*
  • Parkinsonian Disorders / physiopathology
  • Phenotype
  • Substantia Nigra / cytology
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism

Substances

  • Levodopa
  • NADH Dehydrogenase
  • Electron Transport Complex I
  • Ndufs2 protein, mouse
  • Dopamine